Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (121-130 of 411) with videos related to

Pageof 42
Sort By:
Journal of Alzheimer'S Disease : JAD|September 5, 2017
Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case ReportsMarcel Levy Nogueira, Dalila Samri, Stéphane Epelbaum, et al.
Journal of Psychiatric Research|March 12, 2002
Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depressionFrank Padberg, Cornelius Schüle, Peter Zwanzger, et al.
Biological Psychiatry|April 7, 2009
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratioKatharina Buerger, Andrea Ernst, Michael Ewers, et al.
Neurobiology of Aging|November 14, 2006
Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controlsJason P Lerch, Jens Pruessner, Alex P Zijdenbos, et al.
Experimental Neurology|October 10, 2009
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseHarald Hampel, Yong Shen, Dominic M Walsh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2024
Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathwayAya Elhage, Sharon Cohen, Jeffrey Cummings, et al.
Journal of Neurology|March 3, 2006
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRIStefan J Teipel, Jens C Pruessner, Frank Faltraco, et al.
Human Genome Variation|April 16, 2016
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's diseaseEva C Schulte, Alexander Kurz, Panagiotis Alexopoulos, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 1, 2012
Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrumViola Oertel-Knöchel, Christian Knöchel, Anna Rotarska-Jagiela, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2020
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical studyHarald Hampel, Coralie Williams, Adrien Etcheto, et al.
Pageof 42

Showing results (121-130 of 411) with videos related to

Sort By:
Pageof 42
Journal of Alzheimer'S Disease : JAD|September 5, 2017
Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case ReportsMarcel Levy Nogueira, Dalila Samri, Stéphane Epelbaum, et al.
Journal of Psychiatric Research|March 12, 2002
Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depressionFrank Padberg, Cornelius Schüle, Peter Zwanzger, et al.
Biological Psychiatry|April 7, 2009
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratioKatharina Buerger, Andrea Ernst, Michael Ewers, et al.
Neurobiology of Aging|November 14, 2006
Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controlsJason P Lerch, Jens Pruessner, Alex P Zijdenbos, et al.
Experimental Neurology|October 10, 2009
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseHarald Hampel, Yong Shen, Dominic M Walsh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 19, 2024
Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathwayAya Elhage, Sharon Cohen, Jeffrey Cummings, et al.
Journal of Neurology|March 3, 2006
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRIStefan J Teipel, Jens C Pruessner, Frank Faltraco, et al.
Human Genome Variation|April 16, 2016
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's diseaseEva C Schulte, Alexander Kurz, Panagiotis Alexopoulos, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 1, 2012
Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrumViola Oertel-Knöchel, Christian Knöchel, Anna Rotarska-Jagiela, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2020
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical studyHarald Hampel, Coralie Williams, Adrien Etcheto, et al.
Pageof 42